Stock Track | Biostar Pharmaceuticals Soars 30% Following Successful $16 IPO Pricing

Stock Track

2024/10/31

Shares of Beijing Biostar Pharmaceuticals Co Ltd surged 30% on Wednesday, the first trading day after the company announced the final offer price of HK$16.00 (approx. $2.04) per share in its global initial public offering (IPO).

The significant stock price increase reflects strong investor demand for the Chinese biopharmaceutical firm's shares. Biostar Pharmaceuticals raised around $344 million in the Hong Kong IPO, according to Reuters calculations based on the final pricing.

Founded in 2020, Biostar Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing innovative therapeutics for metabolic diseases, oncology, and other areas with high unmet medical needs. The company plans to use the IPO proceeds to fund clinical trials, research and development activities, and potential commercialization of its drug candidates.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/1146934064"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1146934064\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1146934064?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-10-31 09:33","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1146934064","market":"hk","top_or_hot":-1,"title":"Stock Track | Biostar Pharmaceuticals Soars 30% Following Successful $16 IPO Pricing","media":"Stock Track","content":"<p>Shares of Beijing Biostar Pharmaceuticals Co Ltd surged 30% on Wednesday, the first trading day after the company announced the final offer price of HK$16.00 (approx. $2.04) per share in its global initial public offering (IPO).</p>\n\n<p>The significant stock price increase reflects strong investor demand for the Chinese biopharmaceutical firm's shares. Biostar Pharmaceuticals raised around $344 million in the Hong Kong IPO, according to Reuters calculations based on the final pricing.</p>\n\n<p>Founded in 2020, Biostar Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing innovative therapeutics for metabolic diseases, oncology, and other areas with high unmet medical needs. The company plans to use the IPO proceeds to fund clinical trials, research and development activities, and potential commercialization of its drug candidates.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Biostar Pharmaceuticals Soars 30% Following Successful $16 IPO Pricing</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Biostar Pharmaceuticals Soars 30% Following Successful $16 IPO Pricing\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2024-10-31 09:33</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shares of Beijing Biostar Pharmaceuticals Co Ltd surged 30% on Wednesday, the first trading day after the company announced the final offer price of HK$16.00 (approx. $2.04) per share in its global initial public offering (IPO).</p>\n\n<p>The significant stock price increase reflects strong investor demand for the Chinese biopharmaceutical firm's shares. Biostar Pharmaceuticals raised around $344 million in the Hong Kong IPO, according to Reuters calculations based on the final pricing.</p>\n\n<p>Founded in 2020, Biostar Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing innovative therapeutics for metabolic diseases, oncology, and other areas with high unmet medical needs. The company plans to use the IPO proceeds to fund clinical trials, research and development activities, and potential commercialization of its drug candidates.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02563","symbol_name":"华昊中天医药-B","start_time":0,"source_url":"","article_id":"1146934064","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1146934064","pubTimestamp":1730338404,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Shares of Beijing Biostar Pharmaceuticals Co Ltd surged 30% on Wednesday, the first trading day after the company announced the final offer price of HK$16.00  per share in its global initial public offering .The significant stock price increase reflects strong investor demand for the Chinese biopharmaceutical firm's shares. Biostar Pharmaceuticals raised around $344 million in the Hong Kong IPO, according to Reuters calculations based on the final pricing.Founded in 2020, Biostar Pharmaceuticals","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02563":"华昊中天医药-B"},"translate_title":"Biostar Pharmaceuticals成功IPO定价16美元后股价飙升30%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02563":1},"content_text":"Shares of Beijing Biostar Pharmaceuticals Co Ltd surged 30% on Wednesday, the first trading day after the company announced the final offer price of HK$16.00 (approx. $2.04) per share in its global initial public offering (IPO).\nThe significant stock price increase reflects strong investor demand for the Chinese biopharmaceutical firm's shares. Biostar Pharmaceuticals raised around $344 million in the Hong Kong IPO, according to Reuters calculations based on the final pricing.\nFounded in 2020, Biostar Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing innovative therapeutics for metabolic diseases, oncology, and other areas with high unmet medical needs. The company plans to use the IPO proceeds to fund clinical trials, research and development activities, and potential commercialization of its drug candidates.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}